Skip to main content

Table 1 Clinical data of the study subjects

From: Smoking-associated increase in mucins 1 and 4 in human airways

 

Never-smokers

Current Smokers

Current Smokers with COPD

Ex-smokers with COPD

n

40

40

27

11

Male|Female

20|20

20|20

15|12

5|6

Age

57 (6.99)

54 (6.10)

59 (5.05)

60 (5.55)

Pack years

0 (0)

35.2 (12.4)

42.1 (10.2)

29.4 (9.1)

Cigarettes/day past 6 month

0

17.8 (6.61)

16.5 (6.44)

0

FEV1 (% of predicted)

118 (12.8)

109 (11.9)

78.7 (10.5)

78.6 (14.6)

FEV1/FVC

0.81 (0.54)

0.78 (0.47)

0.61 (0.60)

0.60 (0.78)

FEV1/VC

0.80 (0.74)

0.76 (0.63)

0.60 (0.90)

0.56 (0.11)

DLCO (% of predicted)

92.5 (11.3)

79 (12.2)

66.4 (12.5)

69.5 (16.2)

TLC (L)

6.56 (1.23)

6.52 (1.28)

6.66 (1.19)

6.60 (1.04)

Chronic Bronchitis (n)

0

10

7

2

  1. Data is shown as mean and standard deviation. FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, VC Vital capacity, DLCO Diffusing Capacity for Carbon Monoxide, TLC Total Lung Capacity